Stem cell therapies for spinal cord injury

Nat Rev Neurol, 2010 · DOI: 10.1038/nrneurol.2010.73 · Published: July 1, 2010

Spinal Cord Injury Regenerative Medicine Neurology

Simple Explanation

Stem cell therapy offers a potential treatment for spinal cord injury (SCI) by potentially replacing damaged cells, secreting beneficial factors, and regulating scar formation. Many different types of stem cells, including embryonic stem cells, neural stem cells, and stem cells from other tissues, have been tested in SCI models to promote repair and recovery. The potential risks of stem cell therapy, such as tumor formation or abnormal circuit formation, need to be carefully considered against the potential benefits.

Study Duration

Not specified

Participants

Patients with SCI (various studies)

Evidence Level

Review of clinical trials and animal studies

Key Findings

1
Stem cell transplantation strategies for SCI include replacing lost or damaged cells (neurons and oligodendrocytes), providing trophic support, and manipulating the environment to facilitate axon regeneration.
2
Clinical trials of stem cell therapies for SCI have shown some transplants to be safe, but with very limited or no clinically significant therapeutic efficacy.
3
Future strategies involve induced pluripotent stem cells (iPSCs) and modulation of endogenous progenitor cell populations within the spinal cord to promote recovery.

Research Summary

Stem cell therapy holds promise for treating spinal cord injury (SCI) by potentially replacing damaged cells, providing trophic support, and facilitating axon regeneration. While stem cell transplantation has shown functional improvements in animal models of SCI, caution is needed when translating these successes to clinical use. Future strategies for stem cell therapies include using induced pluripotent stem cells and manipulating endogenous stem cell populations to promote recovery after SCI.

Practical Implications

Clinical Trial Design

Careful consideration of injury severity, level, therapeutic goals, and cell type is crucial when designing clinical trials for stem cell therapy in SCI.

Personalized Medicine

The advent of iPSCs offers the exciting prospect of generating patient-specific stem cell lines for transplantation, potentially revolutionizing regenerative medicine.

Combination Therapies

Recovery from SCI will likely require a multifaceted approach combining stem cell therapy with other methodologies to address the complex pathological changes.

Study Limitations

1
Rodent models may not accurately predict therapeutic success in humans.
2
Existing clinical trials have shown limited or no clinically significant therapeutic efficacy.
3
Stem cell transplants carry a risk of tumor growth and neuropathic pain.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury